The global Novel Drug Delivery Systems market size was valued at US$ 23770 million in 2023. With growing demand in downstream market, the Novel Drug Delivery Systems is forecast to a readjusted size of US$ 26870 million by 2030 with a CAGR of 1.8% during review period.
The research report highlights the growth potential of the global Novel Drug Delivery Systems market. Novel Drug Delivery Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Novel Drug Delivery Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Novel Drug Delivery Systems market.
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
Key Features:
The report on Novel Drug Delivery Systems market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Novel Drug Delivery Systems market. It may include historical data, market segmentation by Type (e.g., Liposomes, PEGylated Proteins & Polypeptides), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Novel Drug Delivery Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Novel Drug Delivery Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Novel Drug Delivery Systems industry. This include advancements in Novel Drug Delivery Systems technology, Novel Drug Delivery Systems new entrants, Novel Drug Delivery Systems new investment, and other innovations that are shaping the future of Novel Drug Delivery Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Novel Drug Delivery Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Novel Drug Delivery Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Novel Drug Delivery Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Novel Drug Delivery Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Novel Drug Delivery Systems market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Novel Drug Delivery Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Novel Drug Delivery Systems market.
Market Segmentation:
Novel Drug Delivery Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein鈥揹rug Conjugates
Others
Segmentation by application
Hospitals & Clinic
Cancer Treatment Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Novel Drug Delivery Systems Market Size 2019-2030
2.1.2 Novel Drug Delivery Systems Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Novel Drug Delivery Systems Segment by Type
2.2.1 Liposomes
2.2.2 PEGylated Proteins & Polypeptides
2.2.3 Polymer Nanoparticle
2.2.4 Protein鈥揹rug Conjugates
2.2.5 Others
2.3 Novel Drug Delivery Systems Market Size by Type
2.3.1 Novel Drug Delivery Systems Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Novel Drug Delivery Systems Market Size Market Share by Type (2019-2024)
2.4 Novel Drug Delivery Systems Segment by Application
2.4.1 Hospitals & Clinic
2.4.2 Cancer Treatment Centers
2.4.3 Others
2.5 Novel Drug Delivery Systems Market Size by Application
2.5.1 Novel Drug Delivery Systems Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Novel Drug Delivery Systems Market Size Market Share by Application (2019-2024)
3 Novel Drug Delivery Systems Market Size by Player
3.1 Novel Drug Delivery Systems Market Size Market Share by Players
3.1.1 Global Novel Drug Delivery Systems Revenue by Players (2019-2024)
3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Novel Drug Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Novel Drug Delivery Systems by Regions
4.1 Novel Drug Delivery Systems Market Size by Regions (2019-2024)
4.2 Americas Novel Drug Delivery Systems Market Size Growth (2019-2024)
4.3 APAC Novel Drug Delivery Systems Market Size Growth (2019-2024)
4.4 Europe Novel Drug Delivery Systems Market Size Growth (2019-2024)
4.5 Middle East & Africa Novel Drug Delivery Systems Market Size Growth (2019-2024)
5 Americas
5.1 Americas Novel Drug Delivery Systems Market Size by Country (2019-2024)
5.2 Americas Novel Drug Delivery Systems Market Size by Type (2019-2024)
5.3 Americas Novel Drug Delivery Systems Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Novel Drug Delivery Systems Market Size by Region (2019-2024)
6.2 APAC Novel Drug Delivery Systems Market Size by Type (2019-2024)
6.3 APAC Novel Drug Delivery Systems Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Novel Drug Delivery Systems by Country (2019-2024)
7.2 Europe Novel Drug Delivery Systems Market Size by Type (2019-2024)
7.3 Europe Novel Drug Delivery Systems Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Novel Drug Delivery Systems by Region (2019-2024)
8.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2019-2024)
8.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Novel Drug Delivery Systems Market Forecast
10.1 Global Novel Drug Delivery Systems Forecast by Regions (2025-2030)
10.1.1 Global Novel Drug Delivery Systems Forecast by Regions (2025-2030)
10.1.2 Americas Novel Drug Delivery Systems Forecast
10.1.3 APAC Novel Drug Delivery Systems Forecast
10.1.4 Europe Novel Drug Delivery Systems Forecast
10.1.5 Middle East & Africa Novel Drug Delivery Systems Forecast
10.2 Americas Novel Drug Delivery Systems Forecast by Country (2025-2030)
10.2.1 United States Novel Drug Delivery Systems Market Forecast
10.2.2 Canada Novel Drug Delivery Systems Market Forecast
10.2.3 Mexico Novel Drug Delivery Systems Market Forecast
10.2.4 Brazil Novel Drug Delivery Systems Market Forecast
10.3 APAC Novel Drug Delivery Systems Forecast by Region (2025-2030)
10.3.1 China Novel Drug Delivery Systems Market Forecast
10.3.2 Japan Novel Drug Delivery Systems Market Forecast
10.3.3 Korea Novel Drug Delivery Systems Market Forecast
10.3.4 Southeast Asia Novel Drug Delivery Systems Market Forecast
10.3.5 India Novel Drug Delivery Systems Market Forecast
10.3.6 Australia Novel Drug Delivery Systems Market Forecast
10.4 Europe Novel Drug Delivery Systems Forecast by Country (2025-2030)
10.4.1 Germany Novel Drug Delivery Systems Market Forecast
10.4.2 France Novel Drug Delivery Systems Market Forecast
10.4.3 UK Novel Drug Delivery Systems Market Forecast
10.4.4 Italy Novel Drug Delivery Systems Market Forecast
10.4.5 Russia Novel Drug Delivery Systems Market Forecast
10.5 Middle East & Africa Novel Drug Delivery Systems Forecast by Region (2025-2030)
10.5.1 Egypt Novel Drug Delivery Systems Market Forecast
10.5.2 South Africa Novel Drug Delivery Systems Market Forecast
10.5.3 Israel Novel Drug Delivery Systems Market Forecast
10.5.4 Turkey Novel Drug Delivery Systems Market Forecast
10.5.5 GCC Countries Novel Drug Delivery Systems Market Forecast
10.6 Global Novel Drug Delivery Systems Forecast by Type (2025-2030)
10.7 Global Novel Drug Delivery Systems Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Novel Drug Delivery Systems Product Offered
11.1.3 Amgen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Novel Drug Delivery Systems Product Offered
11.2.3 Teva Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Novel Drug Delivery Systems Product Offered
11.3.3 Roche Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Information
11.4.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Offered
11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 UCB (Union Chimique Belge) Main Business Overview
11.4.5 UCB (Union Chimique Belge) Latest Developments
11.5 Celgene
11.5.1 Celgene Company Information
11.5.2 Celgene Novel Drug Delivery Systems Product Offered
11.5.3 Celgene Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Celgene Main Business Overview
11.5.5 Celgene Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Novel Drug Delivery Systems Product Offered
11.6.3 Merck Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Information
11.7.2 Gilead Sciences Novel Drug Delivery Systems Product Offered
11.7.3 Gilead Sciences Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Gilead Sciences Main Business Overview
11.7.5 Gilead Sciences Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Novel Drug Delivery Systems Product Offered
11.8.3 Sanofi Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Novel Drug Delivery Systems Product Offered
11.9.3 Pfizer Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Novel Drug Delivery Systems Product Offered
11.10.3 Takeda Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Information
11.11.2 Bausch&Lomb Novel Drug Delivery Systems Product Offered
11.11.3 Bausch&Lomb Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Bausch&Lomb Main Business Overview
11.11.5 Bausch&Lomb Latest Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Information
11.12.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offered
11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Samyang Biopharmaceuticals Main Business Overview
11.12.5 Samyang Biopharmaceuticals Latest Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Information
11.13.2 Johnson & Johnson Novel Drug Delivery Systems Product Offered
11.13.3 Johnson & Johnson Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Johnson & Johnson Main Business Overview
11.13.5 Johnson & Johnson Latest Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Information
11.14.2 TOLMAR Novel Drug Delivery Systems Product Offered
11.14.3 TOLMAR Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 TOLMAR Main Business Overview
11.14.5 TOLMAR Latest Developments
11.15 Astellas
11.15.1 Astellas Company Information
11.15.2 Astellas Novel Drug Delivery Systems Product Offered
11.15.3 Astellas Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Astellas Main Business Overview
11.15.5 Astellas Latest Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Information
11.16.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offered
11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 AMAG Pharmaceuticals Main Business Overview
11.16.5 AMAG Pharmaceuticals Latest Developments
11.17 AbbVie
11.17.1 AbbVie Company Information
11.17.2 AbbVie Novel Drug Delivery Systems Product Offered
11.17.3 AbbVie Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 AbbVie Main Business Overview
11.17.5 AbbVie Latest Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Information
11.18.2 Dr Reddy Novel Drug Delivery Systems Product Offered
11.18.3 Dr Reddy Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Dr Reddy Main Business Overview
11.18.5 Dr Reddy Latest Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Information
11.19.2 AstraZeneca Novel Drug Delivery Systems Product Offered
11.19.3 AstraZeneca Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 AstraZeneca Main Business Overview
11.19.5 AstraZeneca Latest Developments
11.20 Aspen
11.20.1 Aspen Company Information
11.20.2 Aspen Novel Drug Delivery Systems Product Offered
11.20.3 Aspen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Aspen Main Business Overview
11.20.5 Aspen Latest Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Information
11.21.2 Acrotech Biopharma Novel Drug Delivery Systems Product Offered
11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Acrotech Biopharma Main Business Overview
11.21.5 Acrotech Biopharma Latest Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Information
11.22.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Offered
11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 TWi Pharmaceuticals Main Business Overview
11.22.5 TWi Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
